Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 40,322 | 26,795 | 13,156 | 11,247 | 4,761 |
| Cost of Goods | 33,484 | 20,988 | 10,383 | 10,938 | 9,437 |
| Gross Profit | 6,838 | 5,807 | 2,773 | 309 | -4,676 |
| Operating Expenses | 6,339 | 6,513 | 384 | 7,499 | 9,351 |
| Operating Income | 983 | 282 | 2,772 | -6,252 | -13,590 |
| Interest Expense | 2,351 | 1,690 | 1,088 | 1,584 | 5,385 |
| Other Income | 889 | -1,142 | -45 | 1,118 | -4,503 |
| Pre-tax Income | -479 | -2,550 | 1,639 | -6,718 | -23,478 |
| Income Tax | 194 | 128 | N/A | -8 | 5 |
| Net Income Continuous | -673 | -2,678 | 1,643 | -6,710 | -23,483 |
| Net Income Discontinuous | 1,579 | -617 | -3,195 | 28,993 | -672 |
| Net Income | $906 | $-3,295 | $-1,552 | $22,283 | $-24,155 |
| EPS Basic Total Ops | 0.11 | -0.41 | 0.68 | 2.82 | -3.68 |
| EPS Basic Continuous Ops | -0.09 | -0.33 | 0.73 | -0.85 | -3.58 |
| EPS Basic Discontinuous Ops | 0.20 | -0.08 | -0.05 | 3.67 | -0.10 |
| EPS Diluted Total Ops | 0.11 | -0.41 | 0.68 | 2.82 | -3.68 |
| EPS Diluted Continuous Ops | -0.09 | -0.33 | 0.73 | -0.85 | -3.58 |
| EPS Diluted Discontinuous Ops | 0.20 | -0.08 | -0.05 | 3.67 | -0.10 |
| EBITDA(a) | $2,344 | $1,623 | $4,311 | $-5,504 | $-8,932 |